Next Article in Journal
A Novel Selective Axl/Mer/CSF1R Kinase Inhibitor as a Cancer Immunotherapeutic Agent Targeting Both Immune and Tumor Cells in the Tumor Microenvironment
Next Article in Special Issue
Women with Cervical High-Risk Human Papillomavirus: Be Aware of Your Anus! The ANGY Cross-Sectional Clinical Study
Previous Article in Journal
Relevance of Abnormal KCNN1 Expression and Osmotic Hypersensitivity in Ewing Sarcoma
Previous Article in Special Issue
Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story
 
 
Article

Article Versions Notes

Cancers 2022, 14(19), 4820; https://doi.org/10.3390/cancers14194820
Action Date Notes Link
article pdf uploaded. 2 October 2022 08:06 CEST Version of Record https://www.mdpi.com/2072-6694/14/19/4820/pdf-vor
article xml file uploaded 9 October 2022 04:16 CEST Original file -
article xml uploaded. 9 October 2022 04:16 CEST Update https://www.mdpi.com/2072-6694/14/19/4820/xml
article pdf uploaded. 9 October 2022 04:16 CEST Updated version of record https://www.mdpi.com/2072-6694/14/19/4820/pdf
article html file updated 9 October 2022 04:18 CEST Original file -
article html file updated 1 March 2023 14:36 CET Update https://www.mdpi.com/2072-6694/14/19/4820/html
Back to TopTop